In patients with SLE there are increased levels of IL-23, IL-21, and IL-17 as a result of the expansion of Th17 cells associated with the depletion of Treg population and increased Th17/Th1 ratio (45, 52). Here, IL17A is linked to systemic lupus erythematosus.